Search Results 841-850 of 17221 for dialysis

  1. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medication, dialysis and kidney transplant.

  2. Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy - Mayo Clinic

    The main purpose of the study is to test if taking a study drug called emricasan (also known as IDN-6556 and PF-03491390) will affect overall patient survival ...

  3. A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Impaired Renal Function - Mayo Clinic

    Group 3: ESRD (not on dialysis) < 15 mL/min/1.73 m^2;; Group 4: ESRD (on dialysis) < 15 mL/min/1.73 m^2; and left ventricular ejection fraction by ...

  4. Kidney infection - Diagnosis and treatment - Mayo Clinic

    A urinary tract infection that travels to the kidneys can be dangerous. Know the symptoms and when to get prompt medical treatment.

  5. Tofacitinib (oral route) - Mayo Clinic

    Liver disease, severe—Use is not recommended in patients with these conditions. Kidney disease (eg, patients on dialysis), moderate or severe or; Liver ...

  6. A Study to Understand Serum Biotin Clearance as a Means to Mitigate the Risk of Biotin Interference with Clinical Laboratory Tests - Mayo Clinic

    Patients with renal impairment: weigh less than 110 lbs, patients on dialysis, pregnant, breast-feeding. mother, intolerance to biotin, currently taking or ...

  7. Resources - Translational Polycystic Kidney Disease (PKD) Center - Mayo Clinic Research

    Get information from Mayo Clinic about polycystic kidney disease (PKD), autosomal dominant polycystic kidney disease (ADPKD) and related kidney diseases.

  8. A Study of the Implementation, Safety, and Outcomes of OB Nest Model of Care for Expectant Mothers - Mayo Clinic

    Isoimmunization (Rh, Kell, etc.) History of transplant or currently on Dialysis; Recurrent pregnancy loss (antiphospholipid antibody syndrome or collagen ...

  9. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

    dialysis at Screening. 11. Hemoglobin concentration <9 g/dL at Screening. 12. Subjects treated with an IV or SC prostacyclin pathway agent (eg, epoprostenol ...

  10. Evaluation of the GORE® Ascending Stent Graft - Mayo Clinic

    ... dialysis 22. Life expectancy \<12 months 23. Known sensitivities or allergies to the device materials 24. Known hypersensitivity or contraindication to ...